loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X

Looking for Controlled & Modified Release? Find Controlled & Modified Release Agents used in Benzocaine to address drug delivery challenges on PharmaCompass.

Filters Filter
Cross PopUp
FILTER :

filter

01 Gangwal Healthcare (2)

02 Nanjing Well Pharmaceutical (4)

03 Actylis (3)

04 BASF (20)

05 Corel Pharma Chem (3)

06 Finar (4)

07 Huzhou Sunflower Pharmaceutical (1)

08 Kerry (5)

09 Lubrizol Life Science Health (6)

10 Nomisma Healthcare (2)

11 The Dow Chemical Company (3)

filter

01 Capsule (8)

02 Cream / Lotion / Ointment (4)

03 Emulsion (1)

04 Gel (4)

05 Granule / Pellet (2)

06 Injectable / Parenteral (1)

07 Orodispersible Tablet (1)

08 Softgel Capsule (1)

09 Softgels (1)

10 Solution (2)

11 Tablet (20)

12 Topical Film (3)

13 Transdermal Patch (4)

14 Transdermal patches (1)

filter

01 China (5)

02 Germany (20)

03 India (11)

04 U.S.A (17)

Close
4

Applications:

For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.

Ingredient(s): Hydrated Silica, Lauryl Sulfate, Polyvinyl Acetate, Povidone

Dosage Form: Capsule, Tablet, Topical Film, Transdermal Patch

Category: Controlled & Modified Release, Direct Compression, Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JP-JPE: 80 % Polyvinyl acetate and 19 % povidone, 0.8 % lauryl sulfate & 0.2 % silica (4:1)

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

PLLA-PEG used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

Ingredient(s): Poly L Lactide, Polyethylene Glycol Excipient

Dosage Form: Tablet

Category: Controlled & Modified Release

Route of Administration (Grade): Oral, Parenteral
Pharmacopoeia Reference: NA

Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

Ingredient(s): Poly-DL-Lactic-co-Glycolic Acid, Polyethylene Glycol Excipients

Dosage Form: Tablet

Category: Controlled & Modified Release

Route of Administration (Grade): Oral, Parenteral
Pharmacopoeia Reference: NA

Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades.

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

POLYETHYLENE GLYCOL 400 NF

URL Supplier Web Content
LM Application #LearnMore

Ingredient(s): polyethylene glycol

Dosage Form: Capsule, Cream / Lotion / Ointment, Gel, Tablet

Category: Controlled & Modified Release, Topical

Route of Administration (Grade): Topical and Oral
Pharmacopoeia Reference: Not Available

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Immediate Release

Ingredient(s): Hydroxypropyl Methylcellulose, Starch

Dosage Form: Tablet

Category: Coating Systems & Additives, Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Customized per requirements

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Immediate Release

Ingredient(s): Glycerol, Unmodified, Hydroxypropyl Methylcellulose

Dosage Form: Tablet

Category: Coating Systems & Additives, Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Customized per requirements

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

POLYETHYLENE GLYCOL 400 NF

URL Supplier Web Content
LM Application #LearnMore

Applications:

A&C's Polyethylene Glycol 400 USP-NF is a short chain non-ionic surfactant.

Ingredient(s): polyethylene glycol

Dosage Form: Cream / Lotion / Ointment, Gel

Category: Topical

Route of Administration (Grade): Topical, Parenteral
Pharmacopoeia Reference: Not Available

Technical Specifications: Low Endotoxin

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Carbopol® 974P NF polymer is used in oral and mucosal contact applications such as oral liquids, bioadhesive formulations, & extended release tablets. Additionally, it can be used to formulate viscous gels, emulsions & suspensions.

Ingredient(s): Carbomer Homopolymer Type B

Dosage Form: Cream / Lotion / Ointment, Emulsion, Gel, Tablet

Category: Controlled & Modified Release, Topical

Route of Administration (Grade): Oral & Topical
Pharmacopoeia Reference: United States Pharmacopeia/National Formulary (USP/NF) monograph for Carbomer Homopolymer Type B, European Pharmacopeia (Ph. Eur.), India Pharmacopeia (IP), China Pharmacopeia (ChP) mongographs for Carbomers.

Technical Specifications: Viscosity, cP (0.5 wt% at pH 7.5)- 29,400 - 39,400

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Noveon® polycarbophil provides excellent bioadhesive properties & can be used for the formulation of buccal, nasal, ophthalmic, rectal bioadhesive products. lt can also be used as a controlled release polymer in oral solid dose applications.

Ingredient(s): Polycarbophil

Dosage Form: Solution, Tablet

Category: Controlled & Modified Release

Route of Administration (Grade): Topical, Oral, Nasal & Ophthalmics
Pharmacopoeia Reference: United States Pharmacopeia/National Formulary (USP/NF) monograph for Polycarbophil.

Technical Specifications: Viscosity, cP (0.2 wt% at pH 7.5) - 2,000 - 12,000

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Enteric Coatings

Ingredient(s): EthylCellulose, Hydroxypropyl Methylcellulose

Dosage Form: Tablet

Category: Coating Systems & Additives, Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Customized per requirements

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Immediate Release

Ingredient(s): Lecithin, Polyvinyl Alcohol

Dosage Form: Tablet

Category: Coating Systems & Additives, Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Customized per requirements

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Immediate Release

Ingredient(s): Hydroxypropyl Cellulose, Hydroxypropyl Methylcellulose

Dosage Form: Tablet

Category: Coating Systems & Additives, Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Customized per requirements

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

XYLITOL MULTI-COMPENDIAL

URL Supplier Web Content
LM Application #LearnMore

Applications:

A & C's Xylitol multi-compendial is an excipient meeting USP-NF, EP and BP monographs.

Ingredient(s): Xylitol Excipient

Dosage Form: Tablet

Category: Controlled & Modified Release, Taste Masking

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Multi-compendial

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

pH-independent sustained release coating for small particles, pellets, granules and tablets. Sprayable polymeric film former. Flexible. Wash resistant.

Ingredient(s): Polyvinyl Acetate, Sodium Lauryl Sulfate

Dosage Form: Capsule, Granule / Pellet, Softgel Capsule, Tablet, Topical Film

Category: Coating Systems & Additives, Controlled & Modified Release, Taste Masking

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Poly(vinyl acetate) dispersion 30 per cent; USP: Polyvinyl Acetate Dispersion

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

NUTRACOAT EC25D

URL Supplier Web Content
LM Application #LearnMore

Applications:

Sustained Release, Taste Masking, Moisture Barrier, Binder in Wet Granulation

Ingredient(s): Ethyl Cellulose

Dosage Form: Capsule, Granule / Pellet, Tablet

Category: Controlled & Modified Release, Fillers, Diluents & Binders, Film Formers & Plasticizers, Granulation, Taste Masking

Route of Administration (Grade): Oral
Pharmacopoeia Reference: USP/NF: Ethyl cellulose dispersion Type B

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubilization, dispersion, crystallization inhibition, instant release matrices & spray drying

Ingredient(s): Povidone

Dosage Form: Capsule, Tablet, Transdermal Patch

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubility and bioavailability enhancement, ideal for hot melt extrusion (HME)

Ingredient(s): polyethylene glycol, Polyvinyl Acetate

Dosage Form: Solution, Tablet, Topical Film, Transdermal Patch

Category: Controlled & Modified Release, Granulation, Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Polyvinyl caprolactam – polyvinyl acetate – polyethylene glycol graft copolymer

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY